| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/13/2006 | US7060481 Comprises peptide for diagnosing and treating inflammatory, tumor, arthritic and nervous system disorders |
| 06/13/2006 | US7060478 mixing an egg white or its diluted solution with diatomaceous earth, kaolin, zeolite or the mixtures thereof, followed by eluting adsorbed lysozyme with a salt solution. |
| 06/13/2006 | US7060474 Carbohydrate oxidase and use thereof in baking |
| 06/13/2006 | US7060472 Preparing calcium phosphate nanoclusters for use in treatment of bone disorders; obtain nanocluster solution, adjust hydrogen ion concentration, recover calcium phosphate nanocluster |
| 06/13/2006 | US7060459 TNF-inducible promoters and methods for using |
| 06/13/2006 | US7060456 Regulation of human protein phosphatase IIc-like enzyme |
| 06/13/2006 | US7060455 Broad specificity DNA damage endonuclease |
| 06/13/2006 | US7060449 Method of preparing GALR2 receptors composition |
| 06/13/2006 | US7060429 Treatment of neurodegenerative diseases by altering levels of TrkB isoforms and/or TrkC isoforms |
| 06/13/2006 | US7060285 Dispersions for the formulation of slightly or poorly soluble agents |
| 06/13/2006 | US7060278 Bv8 nucleic acids and polypeptides with mitogenic activity |
| 06/13/2006 | US7060274 Receptor specific transepithelial transport of therapeutics |
| 06/13/2006 | US7060271 Specifically bind to the extracellular domain of the human type beta PDGF receptor; diagnostic and therapeutic uses |
| 06/13/2006 | US7060269 Anti-VEGF antibodies |
| 06/13/2006 | US7060267 MASP-2, a complement-fixing enzyme, and uses for it |
| 06/13/2006 | US7060266 Human brain carboxypeptidase B |
| 06/13/2006 | US7060265 Cloning and recombinant production of polistinae venom enzymes, such as phospholipase and hyaluronidase, and immunological therapies based thereon |
| 06/13/2006 | US7060264 use of patatin and structurally related proteins which have insect inhibitory properties; Coleoptera; monocotyledons; |
| 06/13/2006 | US7060263 Super absorption Coenzyme Q10 |
| 06/13/2006 | US7060262 Administering granulocyte colony stimulating factor; Crohn's disease |
| 06/13/2006 | US7060261 Nucleotide sequences coding polypeptide for us ein the treatment of immunological disorders |
| 06/13/2006 | US7060260 Water-soluble silk proteins in compositions for skin care, hair care or hair coloring |
| 06/13/2006 | US7060248 Chelate compounds; diagnosis of disease; detection of conjestive heart failurel |
| 06/13/2006 | US7060247 Metal complexed with chelating group attached to gastrin releasing peptide receptor agonist which includes a bombesin agonist binding moiety; for use as therapeutic or diagnostic radiopharmaceutical |
| 06/13/2006 | US7060173 Using Gradiflow electrophoresis technology for macromolecule separation which utilises tangential flow across the membrane |
| 06/13/2006 | US7060059 System and method for initiating and maintaining continuous, long-term control of a concentration of a substance in a patient using a feedback or model-based controller coupled to a single-needle or multi-needle intradermal (ID) delivery device |
| 06/13/2006 | CA2309836C Drug delivery systems utilizing liquid crystal structures |
| 06/13/2006 | CA2282575C Process for preparing a nutritional supplement |
| 06/13/2006 | CA1341508C Transforming growth factor peptides |
| 06/09/2006 | CA2489851A1 Composition for treating psoriasis |
| 06/08/2006 | WO2006060790A2 Neoadjuvant genetic compositions and methods |
| 06/08/2006 | WO2006060680A2 Mda-7 protein variants having antiproliferative activity |
| 06/08/2006 | WO2006060414A2 Compositions and methods for the treatment of autism |
| 06/08/2006 | WO2006060148A2 Novel peptides that bind to the erythropoietin receptor |
| 06/08/2006 | WO2006060120A2 Liposomal formulation for oral administration of glutathione (reduced) |
| 06/08/2006 | WO2006059959A1 Nogo a protein fragments as neuronal network-interacting peptides |
| 06/08/2006 | WO2006059939A1 A medical product comprising a glucagon-like peptide medicament intended for pulmonary inhalation |
| 06/08/2006 | WO2006059914A1 Modulation of ovulation |
| 06/08/2006 | WO2006059913A1 Modulation of ovulation |
| 06/08/2006 | WO2006059846A1 Formulation of sec1 mutated protein and method for formulation of the same |
| 06/08/2006 | WO2006059785A1 Development of bioactive agent using dendritic cell differentiation-inducing factor |
| 06/08/2006 | WO2006059777A1 Remedy for alzheimer’s disease |
| 06/08/2006 | WO2006059638A1 Anti-hiv drug, polypeptide constituting the same, gene encoding the polypeptide and method of producing the anti-hiv drug |
| 06/08/2006 | WO2006059357A2 Use of compounds that interfere with the hedgehog signaling pathway for the manufacture of a medicament for preventing, inhibiting, and/ or reversing ocular diseases related with ocular neovascularization |
| 06/08/2006 | WO2006059227A1 Gem difluorinated c-glycopeptides, their preparation and their use for the preservation of biological materials and/or in cryosurgery |
| 06/08/2006 | WO2006059164A2 Pyrrolopyridine-2-carboxylic acid amides |
| 06/08/2006 | WO2006059131A1 T-cell modulation |
| 06/08/2006 | WO2006059113A2 Fusion proteins comprising a non-cytotoxic protease, a targeting moiety, a protease cleavage site and a translocation domain |
| 06/08/2006 | WO2006059105A2 Non-cytotoxic Protein Conjugates |
| 06/08/2006 | WO2006059093A2 Fusion proteins |
| 06/08/2006 | WO2006059012A1 Antitumor combinations containing a vegf inhibitor and 5fu or one of its derivatives |
| 06/08/2006 | WO2006058620A2 Method for producing carboxy-terminal amidified peptides |
| 06/08/2006 | WO2006058496A1 Mimic antigen epitope of her-2 and composition which comprise such epitope |
| 06/08/2006 | WO2006058486A1 Use of arginase in combination with 5fu and other compounds for treatment of human malignancies |
| 06/08/2006 | WO2006058436A1 Antimicrobial peptides with reduced hemolysis and methods of their use |
| 06/08/2006 | WO2006058434A1 Augmentation of intraluminal microvessel formation to facilitate guide wire crossing in chronic total occlusions |
| 06/08/2006 | WO2006058431A1 Laminin receptor binding molecule |
| 06/08/2006 | WO2006058427A1 Platelet-derived growth factor-responsive neural precursor cells and progeny thereof |
| 06/08/2006 | WO2006058359A2 Protein allergen derivatives |
| 06/08/2006 | WO2006039558A3 Ocular agent delivery systems |
| 06/08/2006 | WO2006035319A3 Methods of using chimeric coiled-coil molecule |
| 06/08/2006 | WO2006032923A3 Inhibitors of protein kinase a anchoring |
| 06/08/2006 | WO2006018431A3 Peptides for the treatment of herpes virus infections |
| 06/08/2006 | WO2006004620A3 Enterotoxin gene cluster (egc) superantigens to treat malignant disease |
| 06/08/2006 | WO2006002968A3 Use of a bacterial phosphoenolpyruvate carboxylase |
| 06/08/2006 | WO2005122723A3 Compositions and methods that enhance articular cartilage repair |
| 06/08/2006 | WO2005120467A3 Dosage form containing the active ingredient cholylsarcosine |
| 06/08/2006 | WO2005116067A3 Msh-agonist tripeptide conjugates |
| 06/08/2006 | WO2005115097A3 Cyclic peptide antibiotics |
| 06/08/2006 | WO2005113585A3 Modified tgf-beta superfamily polypeptides |
| 06/08/2006 | WO2005112985A3 Means and method for diagnosis prophylaxis and therapy of connective tissue diseases |
| 06/08/2006 | WO2005092069A3 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof |
| 06/08/2006 | WO2005090393A3 Multimeric protein toxins to target cells having multiple identifying characteristics |
| 06/08/2006 | WO2005072385A3 Pituitary adenylate cyclase activating peptide (pacap) receptor (vpac2) agonists and their pharmacological methods of use |
| 06/08/2006 | WO2005059161A3 Methods for evaluation a bacteriophage preparation |
| 06/08/2006 | WO2005023862A9 Homogeneous preparations of IL-28 and IL-29 |
| 06/08/2006 | WO2005023191A3 Rage-related methods and compositions for treating glomerular injury |
| 06/08/2006 | WO2005014607A3 Antisense modulation of stearoyl-coa desaturase expression |
| 06/08/2006 | WO2005002527A3 Sirt1 modulation of adipogenesis and adipose function |
| 06/08/2006 | WO2005000878A8 Compositions of lipopeptide antibiotic derivatives and methods of use thereof |
| 06/08/2006 | WO2004084820A9 Method and system for determining insulin dosing schedules and carbohydrate-to-insulin ratios in diabetic patients |
| 06/08/2006 | WO2004014303A3 Method of applying hyaluronic acid to implant or graft to enhance lubricity and cellular density |
| 06/08/2006 | WO2003076571A3 Cancer-linked gene as target for chemotherapy |
| 06/08/2006 | US20060123501 Method for treating inflammatory disorders |
| 06/08/2006 | US20060122391 treatment of RNA viral infections such as HCV, HBV, small pox, Ebola, polio, West Nile, Coxsackie A and B, Rhino, and Echo viral infection; viricides |
| 06/08/2006 | US20060122390 Boronic ester and acid compounds, synthesis and uses |
| 06/08/2006 | US20060122374 Albumin-fused anti-angiogenesis peptides |
| 06/08/2006 | US20060122372 Polymorphisms in the human genes for oct1 and their use in diagnostic and therapeutic applications |
| 06/08/2006 | US20060122371 Process for preparing cardiodilatin fragments; highly purified cardiodilatin fragments and intermediate products for the preparation of same |
| 06/08/2006 | US20060122370 Specific binding agents of human angiopoietin-2 |
| 06/08/2006 | US20060122368 Antigen delivery platform |
| 06/08/2006 | US20060122276 Agent for inhibiting membrane virus reproduction, method for the production thereof, pharmaceutical composition and method for inhibiting viral infections |
| 06/08/2006 | US20060122200 Use and application of a pharmaceutical composition containing a mixture of natural- origin heterocyclical guanidine, for cosmetology, wound healing, focal dystonia and muscular spasm- related clinical pathologies |
| 06/08/2006 | US20060122184 Cyanomethyl derivatives as cysteine protease inhibitors |
| 06/08/2006 | US20060122142 DNA vaccines for farm animals, in particular bovines and porcines |
| 06/08/2006 | US20060122141 For treatment of endocrine-regulated tumors, for example, breast, prostate, ovarian and colon cancers |
| 06/08/2006 | US20060122135 Cloning and expression of a novel member of the Glial cell-line derived neurotrophic factors (GDNF); Parkinson's , Alzheimer's , Huntington's, Creutzfeld-Jacob diseases, neuropathic pain; acute brain injury, multiple sclerosis, amyotrophic lateral sclerosis, peripheral nerve trauma; cancer |
| 06/08/2006 | US20060122134 double-stranded decoy oligonucleotide; atherosclerosis; acts as a competitive inhibitor (or rather neutralisation) of a natural core-binding sequence of a DNA-binding protein or protein complex thereby blocks the expression of the eNOS |
| 06/08/2006 | US20060122133 Antisense modulation of vegf co-regulated chemokine-1 expression |
| 06/08/2006 | US20060122131 Methods for blocking adipocyte differentiation and triglyceride accumulation with transcription factor dp-1 inhibitors |